These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 16368652

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. BMP-2 up-regulates PTEN expression and induces apoptosis of pulmonary artery smooth muscle cells under hypoxia.
    Pi W, Guo X, Su L, Xu W.
    PLoS One; 2012; 7(5):e35283. PubMed ID: 22615735
    [Abstract] [Full Text] [Related]

  • 23. Sildenefil increases connexin 40 in smooth muscle cells through activation of BMP pathways in pulmonary arterial hypertension.
    Yang L, Yin N, Hu L, Fan H, Yu D, Zhang W, Wang S, Feng Y, Fan C, Cao F, Mo X.
    Int J Clin Exp Pathol; 2014; 7(8):4674-84. PubMed ID: 25197339
    [Abstract] [Full Text] [Related]

  • 24. Characterization of the bone morphogenetic protein (BMP) system in human pulmonary arterial smooth muscle cells isolated from a sporadic case of primary pulmonary hypertension: roles of BMP type IB receptor (activin receptor-like kinase-6) in the mitotic action.
    Takeda M, Otsuka F, Nakamura K, Inagaki K, Suzuki J, Miura D, Fujio H, Matsubara H, Date H, Ohe T, Makino H.
    Endocrinology; 2004 Sep; 145(9):4344-54. PubMed ID: 15192043
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Carvedilol inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension.
    Fujio H, Nakamura K, Matsubara H, Kusano KF, Miyaji K, Nagase S, Ikeda T, Ogawa A, Ohta-Ogo K, Miura D, Miura A, Miyazaki M, Date H, Ohe T.
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):250-5. PubMed ID: 16495763
    [Abstract] [Full Text] [Related]

  • 27. Expression of TGF-beta1 and its receptor genes (TbetaR I, TbetaR II, and TbetaR III-betaglycan) in peripheral blood leucocytes in patients with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome.
    Jachec W, Foremny A, Domal-Kwiatkowska D, Smolik S, Tomasik A, Mazurek U, Wodniecki J.
    Int J Mol Med; 2008 Jan; 21(1):99-107. PubMed ID: 18097622
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. FGF12 (Fibroblast Growth Factor 12) Inhibits Vascular Smooth Muscle Cell Remodeling in Pulmonary Arterial Hypertension.
    Yeo Y, Yi ES, Kim JM, Jo EK, Seo S, Kim RI, Kim KL, Sung JH, Park SG, Suh W.
    Hypertension; 2020 Dec; 76(6):1778-1786. PubMed ID: 33100045
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Capsaicin-induced Ca2+ signaling is enhanced via upregulated TRPV1 channels in pulmonary artery smooth muscle cells from patients with idiopathic PAH.
    Song S, Ayon RJ, Yamamura A, Yamamura H, Dash S, Babicheva A, Tang H, Sun X, Cordery AG, Khalpey Z, Black SM, Desai AA, Rischard F, McDermott KM, Garcia JG, Makino A, Yuan JX.
    Am J Physiol Lung Cell Mol Physiol; 2017 Mar 01; 312(3):L309-L325. PubMed ID: 27979859
    [Abstract] [Full Text] [Related]

  • 32. Plasminogen activator inhibitor type 1 inhibits smooth muscle cell proliferation in pulmonary arterial hypertension.
    Kouri FM, Queisser MA, Königshoff M, Chrobak I, Preissner KT, Seeger W, Eickelberg O.
    Int J Biochem Cell Biol; 2008 Mar 01; 40(9):1872-82. PubMed ID: 18337154
    [Abstract] [Full Text] [Related]

  • 33. Bosentan inhibits transient receptor potential channel expression in pulmonary vascular myocytes.
    Kunichika N, Landsberg JW, Yu Y, Kunichika H, Thistlethwaite PA, Rubin LJ, Yuan JX.
    Am J Respir Crit Care Med; 2004 Nov 15; 170(10):1101-7. PubMed ID: 15317671
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Crosstalk between BMP signaling and KCNK3 in phenotypic switching of pulmonary vascular smooth muscle cells.
    Yeo Y, Jeong H, Kim M, Choi Y, Kim KL, Suh W.
    BMB Rep; 2022 Nov 15; 55(11):565-570. PubMed ID: 36016502
    [Abstract] [Full Text] [Related]

  • 36. BMP type II receptor deficiency confers resistance to growth inhibition by TGF-β in pulmonary artery smooth muscle cells: role of proinflammatory cytokines.
    Davies RJ, Holmes AM, Deighton J, Long L, Yang X, Barker L, Walker C, Budd DC, Upton PD, Morrell NW.
    Am J Physiol Lung Cell Mol Physiol; 2012 Mar 15; 302(6):L604-15. PubMed ID: 22227206
    [Abstract] [Full Text] [Related]

  • 37. Dysregulation of the IL-13 receptor system: a novel pathomechanism in pulmonary arterial hypertension.
    Hecker M, Zaslona Z, Kwapiszewska G, Niess G, Zakrzewicz A, Hergenreider E, Wilhelm J, Marsh LM, Sedding D, Klepetko W, Lohmeyer J, Dimmeler S, Seeger W, Weissmann N, Schermuly RT, Kneidinger N, Eickelberg O, Morty RE.
    Am J Respir Crit Care Med; 2010 Sep 15; 182(6):805-18. PubMed ID: 20522789
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. T-type Ca2+ channels elicit pro-proliferative and anti-apoptotic responses through impaired PP2A/Akt1 signaling in PASMCs from patients with pulmonary arterial hypertension.
    Sankhe S, Manousakidi S, Antigny F, Arthur Ataam J, Bentebbal S, Ruchon Y, Lecerf F, Sabourin J, Price L, Fadel E, Dorfmüller P, Eddahibi S, Humbert M, Perros F, Capuano V.
    Biochim Biophys Acta Mol Cell Res; 2017 Oct 15; 1864(10):1631-1641. PubMed ID: 28655554
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.